We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-14.47%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$5.96B
AUM Growth
-$2.66B
Cap. Flow
-$2.46B
Cap. Flow %
-41.33%
Top 10 Hldgs %
19.41%
Holding
1,586
New
385
Increased
156
Reduced
122
Closed
320

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$45.3M
2
DELL icon
Dell
DELL
+$42.5M
3
JD icon
JD.com
JD
+$38.9M
4
TSM icon
TSMC
TSM
+$32.4M
5
ACC
American Campus Communities, Inc.
ACC
+$31.6M

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Financials 9.38%
3 Healthcare 5.16%
4 Consumer Discretionary 4.89%
5 Communication Services 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGGVR
1176
DELISTED
G3 VRM Acquisition Corp. Rights
GGGVR
$23K ﹤0.01%
225,000
MBIO icon
1177
Mustang Bio
MBIO
$4.24M
$21K ﹤0.01%
+47
New +$26K
REKR icon
1178
Rekor Systems
REKR
$86M
$21K ﹤0.01%
+12,063
New +$34.4K
SURF
1179
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$21K ﹤0.01%
+12,608
New +$26.2K
IBIO icon
1180
iBio
IBIO
$72M
$20K ﹤0.01%
+154
New +$23.1K
NCMI icon
1181
National CineMedia
NCMI
$362M
$20K ﹤0.01%
+2,144
New +$36.2K
AWH
1182
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$20K ﹤0.01%
+2,305
New +$23.4K
BSGAR
1183
DELISTED
Blue Safari Group Acquisition Corp. Right
BSGAR
$20K ﹤0.01%
200,000
BFX
1184
DELISTED
BowFlex Inc.
BFX
$19K ﹤0.01%
+10,859
New +$30K
RUBY
1185
DELISTED
Rubius Therapeutics, Inc
RUBY
$19K ﹤0.01%
+21,844
New +$36.7K
FLNT
1186
Fluent
FLNT
$99.9M
$18K ﹤0.01%
+2,577
New +$21.5K
ONCT
1187
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$18K ﹤0.01%
+789
New +$17.6K
KRRO icon
1188
Korro Bio
KRRO
$155M
$17K ﹤0.01%
+231
New +$15.6K
SLDB icon
1189
Solid Biosciences
SLDB
$777M
$17K ﹤0.01%
+1,890
New +$19.6K
TECX
1190
Tectonic Therapeutic
TECX
$578M
$17K ﹤0.01%
+1,502
New +$17.7K
ATNX
1191
DELISTED
Athenex, Inc. Common Stock
ATNX
$17K ﹤0.01%
+2,056
New +$23K
UAVS icon
1192
AgEagle Aerial Systems
UAVS
$41.1M
$16K ﹤0.01%
+25
New +$20.8K
IVC
1193
DELISTED
Invacare Corporation
IVC
$15K ﹤0.01%
+12,005
New +$15.8K
NMMCW
1194
DELISTED
North Mountain Merger Corp. Warrant
NMMCW
$14K ﹤0.01%
45,759
NBEV
1195
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$14K ﹤0.01%
+63,979
New +$24.2K
DNTH icon
1196
Dianthus Therapeutics
DNTH
$5.71B
$13K ﹤0.01%
+667
New +$16.5K
NGNE icon
1197
Neurogene
NGNE
$691M
$13K ﹤0.01%
+628
New +$15.3K
MILE
1198
DELISTED
Metromile, Inc. Common Stock
MILE
$13K ﹤0.01%
+14,556
New +$14.9K
AXDX
1199
DELISTED
Accelerate Diagnostics
AXDX
$12K ﹤0.01%
+1,177
New +$10.4K
BTWNW
1200
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$12K ﹤0.01%
50,000

Similar funds

LMR Partners's Q2 2022 Portfolio in Review

As of Q2 2022, LMR Partners held 1,586 positions worth $5.96B, down 31% from $8.61B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

LMR Partners withdrew a net $2.46B in Q2 2022, closing 320 positions and reducing 122 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $117M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Microsoft worth $42.8M.

  • LMR Partners's largest Q2 2022 buy was Microsoft: 166,753 shares worth $42.8M.
  • LMR Partners added most to TSMC in Q2 2022, an estimated $32.4M increase.
  • LMR Partners's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $553M.
  • LMR Partners fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $117M.
  • LMR Partners's ten largest holdings make up 19% of its $5.96B portfolio in Q2 2022.
  • LMR Partners opened 385 new positions and closed 320 in Q2 2022.
  • LMR Partners's portfolio value fell 31% quarter-over-quarter to $5.96B.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.